NCT05090566 2026-02-23MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple MyelomaPfizerPhase 2 Active not recruiting46 enrolled 15 charts
NCT03785964 2025-01-31DeFiSpringWorks Therapeutics, Inc.Phase 3 Completed142 enrolled 21 charts 1 FDA
NCT00878189 2019-11-12A Trial In Patients With Advanced Cancer And LeukemiaPfizerPhase 1 Completed72 enrolled 49 charts
NCT01876251 2019-03-15A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast CancerPfizerPhase 1 Terminated30 enrolled 29 charts
NCT02109445 2019-01-10Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer TherapiesPfizerPhase 2 Terminated3 enrolled 15 charts
NCT02299635 2019-01-08A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch AlterationsPfizerPhase 2 Terminated19 enrolled 9 charts